Skip all navigation and go to page content
NN/LM Home About SCR | Contact SCR | Feedback |Site Map | Help | Bookmark and Share

New Clinical Advisory

The National Institute of Neurological Disorders and Stroke (NINDS) issued a new Clinical Advisory on September 19, 2011:

Secondary Prevention of Small Subcortical Strokes Trial: NINDS Stops Treatment with Combination Antiplatelet Therapy (Clopidogrel plus Aspirin) Due to Higher Risk of Major Hemorrhage and Death 

NINDS has stopped the combination antiplatelet intervention in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. This was a randomized, multicenter clinical trial conducted throughout North America, Latin America and Spain, to learn about preventing a second stroke in patients who had a subcortical stroke and to learn how to prevent cognitive problems after a stroke.

New Clinical Advisory Issued by National Institute of Neurological Disorders and Stroke (NINDS). NLM Tech Bull. 2011 Sep-Oct;(382):e6.

Bookmark and Share

Comments are closed.